Greater China Digest: Biomissile's Series B; Hashkey eyes funds
Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone.
Stay updated with breaking news from Key Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone.
Two of Southeast Asia's largest tech companies turned in their financial scorecards in the week that went by.
The Hashkey Group is set to raise funds at a $1 billion valuation as it looks to leverage Hond Kong's crypto push.
On a balmy day in mid-April, thousands of people queued in line to enter the Hong Kong Convention Center where the city's inaugural web3 festival was underway.
PLUS: Western crypto innovators with great ideas are eyeing the East for tech-embracing governments and fresh opportunities. A West-East partnership may be crypto's model for the future, the co-founder of Taipei-based Woo Network, Jack Tan, writes..